These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10675737)

  • 1. Urinary nitrate excretion in cholesterol-fed rabbits: effect of a chronic treatment by N-iminoethyl-L-lysine, a selective inhibitor of inducible nitric oxide synthase.
    Behr-Roussel D; Rupin A; Simonet S; Fabiani J; Verbeuren TJ
    Eur J Pharmacol; 2000 Feb; 388(3):275-9. PubMed ID: 10675737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits.
    Behr-Roussel D; Rupin A; Simonet S; Bonhomme E; Coumailleau S; Cordi A; Serkiz B; Fabiani JN; Verbeuren TJ
    Circulation; 2000 Aug; 102(9):1033-8. PubMed ID: 10961969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for superoxide anion generation in aortas of cholesterol-fed rabbits treated with L-arginine.
    Simonet S; Rupin A; Badier-Commander C; Coumailleau S; Behr-Roussel D; Verbeuren TJ
    Eur J Pharmacol; 2004 May; 492(2-3):211-6. PubMed ID: 15178367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
    Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritis.
    Westenfeld R; Gawlik A; de Heer E; Kitahara M; Abou-Rebyeh F; Floege J; Ketteler M
    Kidney Int; 2002 Mar; 61(3):834-8. PubMed ID: 11849434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine.
    Walker LM; Walker PD; Imam SZ; Ali SF; Mayeux PR
    J Pharmacol Exp Ther; 2000 Oct; 295(1):417-22. PubMed ID: 10992009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury.
    Lianos EA; Guglielmi K; Sharma M
    Kidney Int; 1998 Mar; 53(3):645-53. PubMed ID: 9507210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin.
    Böger RH; Bode-Böger SM; Brandes RP; Phivthong-ngam L; Böhme M; Nafe R; Mügge A; Frölich JC
    Circulation; 1997 Aug; 96(4):1282-90. PubMed ID: 9286960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
    Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
    Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease.
    McCartney-Francis NL; Song X; Mizel DE; Wahl SM
    J Immunol; 2001 Feb; 166(4):2734-40. PubMed ID: 11160339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics.
    Hansel TT; Kharitonov SA; Donnelly LE; Erin EM; Currie MG; Moore WM; Manning PT; Recker DP; Barnes PJ
    FASEB J; 2003 Jul; 17(10):1298-300. PubMed ID: 12738811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercholesterolemia impairs basal nitric oxide synthase turnover rate: a study investigating the conversion of L-[guanidino-(15)N(2)]-arginine to (15)N-labeled nitrate by gas chromatography--mass spectrometry.
    Böger RH; Tsikas D; Bode-Böger SM; Phivthong-Ngam L; Schwedhelm E; Frölich JC
    Nitric Oxide; 2004 Aug; 11(1):1-8. PubMed ID: 15350551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits.
    Bode-Böger SM; Böger RH; Kienke S; Junker W; Frölich JC
    Biochem Biophys Res Commun; 1996 Feb; 219(2):598-603. PubMed ID: 8605033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
    Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
    Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor.
    Hallinan EA; Tsymbalov S; Dorn CR; Pitzele BS; Hansen DW; Moore WM; Jerome GM; Connor JR; Branson LF; Widomski DL; Zhang Y; Currie MG; Manning PT
    J Med Chem; 2002 Apr; 45(8):1686-9. PubMed ID: 11931623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
    Bryk R; Wolff DJ
    Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
    Theuer J; Shagdarsuren E; Muller DN; Kaergel E; Honeck H; Park JK; Fiebeler A; Dechend R; Haller H; Luft FC; Schunck WH
    Kidney Int; 2005 Jan; 67(1):248-58. PubMed ID: 15610248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of inducible nitric oxide synthase inhibition on kidney function and structure in high-fat diet-induced kidney disease.
    Martin B; Caron N; Jadot I; Colombaro V; Federici G; Depommier C; Declèves AÉ
    Exp Physiol; 2018 Jan; 103(1):125-140. PubMed ID: 28944982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm.
    Harkin DW; Rubin BB; Romaschin A; Lindsay TF
    J Surg Res; 2004 Aug; 120(2):230-41. PubMed ID: 15234218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.